Literature DB >> 30182520

MicroRNA expression analysis of human skin fibroblasts treated with high-fluence light-emitting diode-red light.

Andrew Mamalis1,2, Eugene Koo2,3, Clifford Tepper4, Jared Jagdeo1,2,3.   

Abstract

Skin fibrosis is a chronic debilitating feature of several skin diseases that lead to characteristic increases in dermal fibroblast proliferation and collagen deposition through upregulation in components of the transforming growth factor beta (TGF-B)/SMAD pathway. In contrast to ultraviolet phototherapy, high-fluence light-emitting diode-generated red light (HF-LED-RL, 633 ± 15 nm) is a safe, economic and non-invasive therapy with in vitro evidence that supports modulation of the key cellular characteristics involved in the pathogenesis of skin fibrosis. Limited data exists pertaining to the effects of HF-LED-RL on human skin fibroblast microRNA (miRNA). Herein, we explored the effects of HF-LED-RL on fibroblast miRNA levels using RNA-seq and miRNA expression analysis. Using RNA-seq analysis we found that HF-LED-RL at 320 and 640 J/cm2 increased transcription of key miRNA that are involved in skin fibrosis including miRNA-29, miRNA-196a and Let-7a, and decreased transcription of miRNA-21, miRNA-23b and miRNA-31. These microRNA findings provide insight into the molecular underpinnings of HF-LED-RL and highlight potential therapeutic targets of interest for the treatment of skin fibrosis. Additional research on the specific molecular mechanisms underlying HF-LED-RL effects on fibroblasts may provide further mechanistic insight into this therapy and may reveal additional future therapeutic targets for skin fibrosis.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  LED, light emitting diode; RNA-seq; Skin fibrosis; fibroblasts; phototherapy; red light; transcriptome

Mesh:

Substances:

Year:  2019        PMID: 30182520      PMCID: PMC6401359          DOI: 10.1002/jbio.201800207

Source DB:  PubMed          Journal:  J Biophotonics        ISSN: 1864-063X            Impact factor:   3.207


  29 in total

Review 1.  Skin scarring.

Authors:  A Bayat; D A McGrouther; M W J Ferguson
Journal:  BMJ       Date:  2003-01-11

Review 2.  Mechanisms of fibrosis: therapeutic translation for fibrotic disease.

Authors:  Thomas A Wynn; Thirumalai R Ramalingam
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

Review 3.  MicroRNA-29: a potential therapeutic target for systemic sclerosis.

Authors:  Wen-Jia Peng; Jin-Hui Tao; Bin Mei; Bing Chen; Bao-Zhu Li; Guo-Jun Yang; Qiong Zhang; Hua Yao; Bing-Xiang Wang; Qian He; Jing Wang
Journal:  Expert Opin Ther Targets       Date:  2012-07-16       Impact factor: 6.902

4.  TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts.

Authors:  Noritoshi Honda; Masatoshi Jinnin; Ikko Kajihara; Takamitsu Makino; Katsunari Makino; Shinichi Masuguchi; Satoshi Fukushima; Yoshinobu Okamoto; Minoru Hasegawa; Manabu Fujimoto; Hironobu Ihn
Journal:  J Immunol       Date:  2012-02-29       Impact factor: 5.422

5.  Fast gapped-read alignment with Bowtie 2.

Authors:  Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

6.  MicroRNA array analysis of microRNAs related to systemic scleroderma.

Authors:  Haitao Li; Rongya Yang; Xin Fan; Tingmin Gu; Zhili Zhao; Dongqing Chang; Wenling Wang; Congmin Wang
Journal:  Rheumatol Int       Date:  2010-10-30       Impact factor: 2.631

7.  MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.

Authors:  Britta Maurer; Joanna Stanczyk; Astrid Jüngel; Alfiya Akhmetshina; Michelle Trenkmann; Matthias Brock; Otylia Kowal-Bielecka; Renate E Gay; Beat A Michel; Jörg H W Distler; Steffen Gay; Oliver Distler
Journal:  Arthritis Rheum       Date:  2010-06

8.  FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.

Authors:  C-S Wu; P-H Wu; A-H Fang; C-C E Lan
Journal:  Br J Dermatol       Date:  2012-07-19       Impact factor: 9.302

9.  miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades.

Authors:  Marc R Friedländer; Sebastian D Mackowiak; Na Li; Wei Chen; Nikolaus Rajewsky
Journal:  Nucleic Acids Res       Date:  2011-09-12       Impact factor: 16.971

10.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.

Authors:  Mark D Robinson; Davis J McCarthy; Gordon K Smyth
Journal:  Bioinformatics       Date:  2009-11-11       Impact factor: 6.937

View more
  4 in total

1.  Light emitting diode-red light for reduction of post-surgical scarring: Results from a dose-ranging, split-face, randomized controlled trial.

Authors:  Alana Kurtti; Julie K Nguyen; Jeremy Weedon; Andrew Mamalis; Yi Lai; Natasha Masub; Amaris Geisler; Daniel M Siegel; Jared R Jagdeo
Journal:  J Biophotonics       Date:  2021-05-04       Impact factor: 3.207

2.  Transcriptome analysis of human dermal fibroblasts following red light phototherapy.

Authors:  Evan Austin; Eugene Koo; Alexander Merleev; Denis Torre; Alina Marusina; Guillaume Luxardi; Andrew Mamalis; Roslyn Rivkah Isseroff; Avi Ma'ayan; Emanual Maverakis; Jared Jagdeo
Journal:  Sci Rep       Date:  2021-04-01       Impact factor: 4.379

3.  MicroRNA-411-3p inhibits bleomycin-induced skin fibrosis by regulating transforming growth factor-β/Smad ubiquitin regulatory factor-2 signalling.

Authors:  Ziyan Zhang; Xuemin Gao; Yang He; Yumeng Kang; Fuyu Jin; Yaqian Li; Tian Li; Zhongqiu Wei; Shifeng Li; Wenchen Cai; Na Mao; Shan Wang; Heliang Liu; Fang Yang; Hong Xu; Jie Yang
Journal:  J Cell Mol Med       Date:  2021-11-15       Impact factor: 5.310

4.  Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022.

Authors:  Jolien Robijns; Raj G Nair; Joy Lodewijckx; Praveen Arany; Andrei Barasch; Jan M Bjordal; Paolo Bossi; Anne Chilles; Patricia M Corby; Joel B Epstein; Sharon Elad; Reza Fekrazad; Eduardo Rodrigues Fregnani; Marie-Thérèse Genot; Ana M C Ibarra; Michael R Hamblin; Vladimir Heiskanen; Ken Hu; Jean Klastersky; Rajesh Lalla; Sofia Latifian; Arun Maiya; Jeroen Mebis; Cesar A Migliorati; Dan M J Milstein; Barbara Murphy; Judith E Raber-Durlacher; Hendrik J Roseboom; Stephen Sonis; Nathaniel Treister; Yehuda Zadik; René-Jean Bensadoun
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.